Breaking Down Jiangsu Zongyi Co.,LTD Financial Health: Key Insights for Investors

Breaking Down Jiangsu Zongyi Co.,LTD Financial Health: Key Insights for Investors

CN | Technology | Semiconductors | SHH

Jiangsu Zongyi Co.,LTD (600770.SS) Bundle

Get Full Bundle:
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

Jiangsu Zongyi's nine-month revenue jump to CNY 323.61 million (a year‑over‑year rise of 28.7%) and a trailing‑12‑month revenue of CNY 419.97 million sit alongside a solid gross margin of 29.83% and positive net profit margin of 8.69%, yet investors should note the operating margin of -10.58%, slim ROE (1.68%) and EPS of CNY 0.04 (P/E signaling mixed valuation signals), counterbalanced by a conservative capital structure with debt‑to‑equity at 9.6%, a net cash position of CNY 1.39 billion, robust liquidity (current ratio 3.69, quick ratio 3.35) and an Altman Z‑Score of 3.82 - even as market pricing (market price CNY 6.06 vs. estimated intrinsic value CNY 1.03, implying ~83% overvaluation) and stretched EV/EBITDA (104.67) raise sharp valuation questions; read on for a line‑by‑line breakdown of revenue trends, profitability metrics, balance‑sheet strength, valuation multiples and the growth opportunities and risks shaping investor decisions.

Jiangsu Zongyi Co.,LTD (600770.SS) - Revenue Analysis

Jiangsu Zongyi Co.,LTD reported notable top-line dynamics through recent periods, with strong quarterly momentum and mixed longer-term trends. Key figures and trends below provide a snapshot of revenue performance, efficiency per employee, and margin structure.
  • Nine months ended Sep 30, 2025 revenue: CNY 323.61 million (YoY +28.7% vs CNY 251.54 million).
  • Latest quarter revenue: CNY 111.45 million, up 9.5% QoQ from CNY 101.70 million.
  • Trailing twelve months (TTM) revenue: CNY 419.97 million (vs prior-year TTM CNY 409.68 million - modest increase).
  • Five-year revenue CAGR (approx.): -1.74% (slight decline over five years).
  • Revenue per employee: CNY 797,050 with 514 employees.
  • TTM gross margin: 29.83%.
Metric Value Period / Comment
Revenue (9M) CNY 323.61M Nine months ended Sep 30, 2025
Revenue (9M prior year) CNY 251.54M Nine months ended Sep 30, 2024
Revenue (TTM) CNY 419.97M Trailing twelve months
Revenue (TTM prior) CNY 409.68M Prior trailing twelve months
Latest quarter revenue CNY 111.45M Most recent quarter reported
Previous quarter revenue CNY 101.70M Quarter before latest
QoQ growth ~9.5% Quarter-over-quarter
YoY (9M) growth ~28.7% Nine months vs prior year
5-year revenue growth rate -1.74% Approximate
Revenue per employee CNY 797,050 514 employees
Gross margin (TTM) 29.83% Trailing twelve months
  • Short-term momentum: accelerating sequential revenue with a +9.5% QoQ increase in the latest quarter and strong 9M YoY growth of ~28.7%.
  • Longer-term context: TTM revenue shows only modest improvement vs prior TTM, and five-year growth rate is slightly negative (-1.74%), indicating structural headwinds or cyclicality.
  • Profitability and efficiency: a TTM gross margin of 29.83% combined with revenue per employee of CNY 797,050 points to moderate margin retention and mid-range workforce productivity for the company's industry niche.
Exploring Jiangsu Zongyi Co.,LTD Investor Profile: Who's Buying and Why?

Jiangsu Zongyi Co.,LTD (600770.SS) - Profitability Metrics

  • Net profit margin (TTM): 8.69% - ability to convert revenue into net income.
  • Gross margin (TTM): 29.83% - portion of revenue retained after direct costs.
  • Operating margin (TTM): -10.58% - core operations currently showing an operating loss.
  • Return on equity (ROE, TTM): 1.68% - modest efficiency in generating profits from shareholders' equity.
  • Earnings per share (EPS, TTM): CNY 0.04; Price-to-earnings (P/E): 145.30 - high valuation relative to earnings.
  • Net income (9 months ended Sep 30, 2025): CNY 90.80 million - up from CNY 72.15 million YoY (≈25.9%).
Metric Value Period/Notes
Net Profit Margin 8.69% Trailing twelve months
Gross Margin 29.83% Trailing twelve months
Operating Margin -10.58% Trailing twelve months (operating loss)
Return on Equity (ROE) 1.68% Trailing twelve months
Earnings per Share (EPS) CNY 0.04 Trailing twelve months
Price-to-Earnings (P/E) 145.30 Market valuation relative to EPS
Net Income (9 months) CNY 90.80 million 9 months ended Sep 30, 2025 (↑ 25.9% YoY from CNY 72.15M)

For additional corporate context and how the business generates revenue, see: Jiangsu Zongyi Co.,LTD: History, Ownership, Mission, How It Works & Makes Money

Jiangsu Zongyi Co.,LTD (600770.SS) Debt vs. Equity Structure

Jiangsu Zongyi's capital structure shows low leverage, strong equity backing and a meaningful net cash position, supporting financial flexibility for operations, capex and shareholder returns.

  • Debt-to-equity ratio: 9.6% - indicates conservative use of debt.
  • Total debt: CNY 466.1 million versus total equity: CNY 4.87 billion.
  • Total assets: CNY 6.1 billion; total liabilities: CNY 1.2 billion; debt-to-assets ≈ 19.7%.
  • Interest coverage ratio: not available - limits assessment of interest-service capacity from operating earnings.
  • Net cash position: CNY 1.39 billion - strong liquidity buffer.
  • Equity (book value): CNY 4.56 billion; book value per share: CNY 2.59.
Metric Amount (CNY) Ratio / Per-share
Total Debt 466,100,000 -
Total Equity 4,870,000,000 -
Total Assets 6,100,000,000 -
Total Liabilities 1,200,000,000 -
Debt-to-Equity Ratio - 9.6%
Debt-to-Assets Ratio - ≈19.7%
Net Cash Position 1,390,000,000 -
Book Value (Equity) 4,560,000,000 -
Book Value per Share - 2.59
Interest Coverage Not available -

For investor-level context and shareholder activity details, see: Exploring Jiangsu Zongyi Co.,LTD Investor Profile: Who's Buying and Why?

Jiangsu Zongyi Co.,LTD (600770.SS) - Liquidity and Solvency

Jiangsu Zongyi's balance-sheet strength is highlighted by high short-term coverage, a conservative leverage profile and a solid cash position, while operating cash generation fell short of capex this period.
  • Current ratio: 3.69 - ample ability to cover short-term liabilities with short-term assets.
  • Quick ratio: 3.35 - strong liquidity even after excluding inventory.
  • Debt-to-assets ratio: ~19.7% - total liabilities of CNY 1.24 billion vs. total assets of CNY 6.10 billion.
  • Net cash position: CNY 1.39 billion - indicates meaningful financial flexibility.
  • Operating cash flow: CNY 38.53 million; Capital expenditures: CNY 46.72 million; Free cash flow: -CNY 8.20 million.
  • Altman Z-Score: 3.82 - low bankruptcy risk by the standard metric.
Metric Value
Current Ratio 3.69
Quick Ratio 3.35
Total Assets CNY 6.10 billion
Total Liabilities CNY 1.24 billion
Debt-to-Assets Ratio 19.7%
Net Cash Position CNY 1.39 billion
Operating Cash Flow CNY 38.53 million
Capital Expenditures CNY 46.72 million
Free Cash Flow -CNY 8.20 million
Altman Z-Score 3.82
For additional context on ownership, trading and investor composition, see: Exploring Jiangsu Zongyi Co.,LTD Investor Profile: Who's Buying and Why?

Jiangsu Zongyi Co.,LTD (600770.SS) - Valuation Analysis

Key market and valuation metrics for Jiangsu Zongyi Co.,LTD (600770.SS) indicate a stretched market valuation versus fundamentals across multiple measures. Below are the primary figures investors should note and consider when evaluating this stock.

Metric Value Implication
TTM P/E 68.55 High multiple on trailing earnings
Enterprise Value (EV) CNY 7.21 billion Firm market + debt valuation
EV/EBITDA 104.67 Very high relative to operating profits
Estimated Intrinsic Value (per share) CNY 1.03 Model-based fair value estimate
Current Market Price (per share) CNY 6.06 Market price
Implied Overvaluation ~83% Market price vs intrinsic value
P/S 18.09 High price relative to sales
P/B 1.63 Moderate premium to book value
P/FCF N/A Free cash flow valuation not available
P/OCF 192.33 Extremely high relative to operating cash flow
  • Valuation stretch: P/E of 68.55 and EV/EBITDA of 104.67 both signal market expectations of strong future earnings or lower current profitability; either scenario raises risk if growth disappoints.
  • Price vs intrinsic: Current price CNY 6.06 vs intrinsic CNY 1.03 implies market premium ≈83%; investors should treat the intrinsic estimate as model-dependent and stress-test inputs.
  • Cash flow opacity: P/FCF not available while P/OCF is 192.33 - limited free-cash-flow visibility increases uncertainty about sustainable cash generation.

Practical considerations for investors:

  • Scenario analysis: Recalculate intrinsic value under conservative growth and margin assumptions to assess downside risk.
  • Liquidity and leverage: Cross-check EV components (net debt vs cash) to understand how much of EV is driven by leverage.
  • Peer context: Compare these ratios to industry peers to determine whether high multiples reflect sector-wide dynamics or company-specific factors.
  • Data gaps: Seek latest cash-flow statements and management commentary to resolve the P/FCF data gap before relying on valuation conclusions.

For additional context on corporate priorities and strategic positioning, see: Mission Statement, Vision, & Core Values (2026) of Jiangsu Zongyi Co.,LTD.

Jiangsu Zongyi Co.,LTD (600770.SS) - Risk Factors

Key financial risks that investors should weigh when evaluating Jiangsu Zongyi Co.,LTD (600770.SS):

  • Operating margin: -10.58% - core operations are running at a loss, signaling difficulty in covering operating costs from revenues.
  • Return on assets (ROA): -0.51% - the company is not efficiently converting asset base into profits.
  • Return on invested capital (ROIC): -0.56% - invested capital is generating negative returns, limiting value creation for shareholders.
  • 5‑year EPS growth: -14.61% - earnings per share have declined materially over the past five years, indicating recurring profitability pressures or dilution.
  • Net profit margin: 8.69% - below industry average, reflecting weaker bottom-line performance relative to peers.
  • Debt-to-equity: 9.6% - relatively conservative leverage, but the company's low interest coverage ratio makes it hard to confirm capacity to meet interest obligations from operating earnings.
Metric Value Implication
Operating margin -10.58% Loss-making on core operations; risk of continued operating cash shortfalls
ROA -0.51% Inefficient asset utilization
ROIC -0.56% Negative returns on invested capital
EPS 5‑yr growth -14.61% Sustained decline in per-share earnings
Net profit margin 8.69% Below-industry profitability
Debt-to-equity 9.6% Low leverage, but interest coverage concerns persist
Interest coverage ratio Low / Limited disclosure Insufficient cushion to reliably meet interest expenses from operations

For more context on ownership, trading patterns, and investor composition that may interact with these risk factors, see: Exploring Jiangsu Zongyi Co.,LTD Investor Profile: Who's Buying and Why?

Jiangsu Zongyi Co.,LTD (600770.SS) - Growth Opportunities

  • Renewable energy footprint across multiple markets: active in construction and management of photovoltaic power stations in the Czech Republic, Italy, United States, Germany, Bulgaria, Romania, and China (7 countries), positioning the company to capture growth from global solar demand and cross-border project revenue streams.
  • Medical-device R&D: ongoing development of ultra-low-power digital-analog hybrid hearing-aid chips and high-end digital voice processing technology, creating potential for high-margin product lines and licensing opportunities.
  • Semiconductor expansion: signed a deal to acquire a 15.86% stake in Jiangsu Jilai Microelectronics Co., Ltd., indicating strategic vertical integration into the semiconductor supply chain.
  • Diversification: operations span traditional Chinese medicine, new materials, photovoltaic power, semiconductors, medical devices, and equity investments-spreading down-cycle risk and opening multiple revenue channels.
  • Market sentiment and risk profile: a 143.59% increase in market capitalization over the past year signals strong investor interest, while a beta of 0.26 implies low volatility relative to the broader market-appealing to growth-seeking but risk-conscious investors.
Metric Value Notes
Countries with PV projects 7 Czech Rep., Italy, USA, Germany, Bulgaria, Romania, China
Stake in Jiangsu Jilai Microelectronics 15.86% Signed acquisition agreement
Market capitalization change (1 yr) +143.59% Indicates strong Y/Y valuation growth
Beta 0.26 Lower volatility vs. market
Business segments Photovoltaics, Medical Devices, Semiconductors, TCM, New Materials, Equity Investments Diversified revenue base
  • Key growth levers to monitor:
    • Project pipeline and capacity additions in Europe, North America, and China (timing and tariff/REC exposure).
    • Commercialization milestones and margins for hearing-aid chip and voice-processing products.
    • Progress and integration benefits from the 15.86% Jilai Microelectronics stake (supply security, cost reduction, IP access).
    • Performance of non-core segments (TCM, new materials) and their contribution to consolidated cash flow.
    • Share-price sensitivity given recent market-cap surge vs. low-beta profile-watch liquidity and institutional holdings.
Jiangsu Zongyi Co.,LTD: History, Ownership, Mission, How It Works & Makes Money

DCF model

Jiangsu Zongyi Co.,LTD (600770.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.